Global pharmaceutical company Alkomex GBN is expanding its research and development operations into India. The company has appointed nutraceuticals expert Dr. Sanjay Agrawal as Scientific Advisor to lead these efforts. Based in Ahmedabad, Dr. Agrawal will oversee research and strategic initiatives, integrating Indian research into Alkomex's global operations.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O0euwlI
via IFTTT
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(740)
-
▼
November
(10)
- Health groups raise concerns over patents for rare...
- Venus Remedies gets GMP approval for pre-filled sy...
- CDSCO may regulate health supplements to stem unap...
- US firm Alkomex to expand R&D footprint in India
- FSSAI sets stricter rule for antibiotics in food i...
- Bajra roti or wheat roti? Which is better for heal...
- Dr Reddy's recalls over 3.3 lakh bottles of generi...
- Apollo Hospitals announces Rs 1,625 crore expansio...
- From fish to seeds: 5 excellent sources of Omega-3...
- Suven, Cohance aim to double combined business rev...
-
▼
November
(10)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment